Skuldtech, AB Science to Develop CDx for Pancreatic Cancer Drug
November 05, 2012
Skuldtech, AB Science to Develop CDx for Pancreatic Cancer Drug
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- AB Science, Skuldtech Developing Companion Dx to Predict Masitinib Response in Pancreatic Cancer
November 14, 2012 / Pharmacogenomics Reporter - Abbott to Develop Companion Dx for Epizyme Cancer Drug Candidate
April 18, 2013 / GenomeWeb Daily News - Foundation Medicine to Develop Dx for Agios Cancer Therapeutics
April 4, 2013 / GenomeWeb Daily News - Merck, Luminex Partner to Advance Companion Test for Alzheimer's Drug
March 13, 2013 / GenomeWeb Daily News - Leica, Synthon Biopharmaceuticals Partner on CDx Development
March 12, 2013 / GenomeWeb Daily News